Literature DB >> 25332239

JAK2 tyrosine kinase phosphorylates and is negatively regulated by centrosomal protein Ninein.

Jennifer Jay1, Alan Hammer1, Andrea Nestor-Kalinoski2, Maria Diakonova3.   

Abstract

JAK2 is a cytoplasmic tyrosine kinase critical for cytokine signaling. In this study, we have identified a novel centrosome-associated complex containing ninein and JAK2. We have found that active JAK2 localizes around the mother centrioles, where it partly colocalizes with ninein, a protein involved in microtubule (MT) nucleation and anchoring. We demonstrated that JAK2 is an important regulator of centrosome function. Depletion of JAK2 or use of JAK2-null cells causes defects in MT anchoring and increased numbers of cells with mitotic defects; however, MT nucleation is unaffected. We showed that JAK2 directly phosphorylates the N terminus of ninein while the C terminus of ninein inhibits JAK2 kinase activity in vitro. Overexpressed wild-type (WT) or C-terminal (amino acids 1179 to 1931) ninein inhibits JAK2. This ninein-dependent inhibition of JAK2 significantly decreases prolactin- and interferon gamma (IFN-γ)-induced tyrosyl phosphorylation of STAT1 and STAT5. Downregulation of ninein enhances JAK2 activation. These results indicate that JAK2 is a novel member of centrosome-associated complex and that this localization regulates both centrosomal function and JAK2 kinase activity, thus controlling cytokine-activated molecular pathways.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25332239      PMCID: PMC4295371          DOI: 10.1128/MCB.01138-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  91 in total

1.  Kinase activity and subcellular distribution of a chimeric green fluorescent protein-tagged Janus kinase 2.

Authors:  Sheeyong Lee; Roy J Duhé
Journal:  J Biomed Sci       Date:  2006-09-14       Impact factor: 8.410

2.  Novel asymmetrically localizing components of human centrosomes identified by complementary proteomics methods.

Authors:  Lis Jakobsen; Katja Vanselow; Marie Skogs; Yusuke Toyoda; Emma Lundberg; Ina Poser; Lasse G Falkenby; Martin Bennetzen; Jens Westendorf; Erich A Nigg; Mathias Uhlen; Anthony A Hyman; Jens S Andersen
Journal:  EMBO J       Date:  2011-03-11       Impact factor: 11.598

3.  Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase.

Authors:  P A Ram; D J Waxman
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

4.  Oncogenic tyrosine kinase of malignant hemopathy targets the centrosome.

Authors:  Bénédicte Delaval; Sébastien Létard; Hélène Lelièvre; Véronique Chevrier; Laurent Daviet; Patrice Dubreuil; Daniel Birnbaum
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

5.  Multipolar spindle pole coalescence is a major source of kinetochore mis-attachment and chromosome mis-segregation in cancer cells.

Authors:  William T Silkworth; Isaac K Nardi; Lindsey M Scholl; Daniela Cimini
Journal:  PLoS One       Date:  2009-08-10       Impact factor: 3.240

6.  Jamip1 (marlin-1) defines a family of proteins interacting with janus kinases and microtubules.

Authors:  Corinna Steindler; Zhi Li; Michèle Algarté; Andrès Alcover; Valentina Libri; Josiane Ragimbeau; Sandra Pellegrini
Journal:  J Biol Chem       Date:  2004-07-23       Impact factor: 5.157

Review 7.  Aneuploidy and cancer.

Authors:  Harith Rajagopalan; Christoph Lengauer
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

8.  Stat3 activity is required for centrosome duplication in chinese hamster ovary cells.

Authors:  Brandon Metge; Solomon Ofori-Acquah; Troy Stevens; Ron Balczon
Journal:  J Biol Chem       Date:  2004-08-04       Impact factor: 5.157

9.  Microtubule minus-end anchorage at centrosomal and non-centrosomal sites: the role of ninein.

Authors:  M M Mogensen; A Malik; M Piel; V Bouckson-Castaing; M Bornens
Journal:  J Cell Sci       Date:  2000-09       Impact factor: 5.285

10.  Centrioles in the cell cycle. I. Epithelial cells.

Authors:  I A Vorobjev
Journal:  J Cell Biol       Date:  1982-06       Impact factor: 10.539

View more
  10 in total

1.  JAK2 gene knockout inhibits corneal allograft rejection in mice by regulating dendritic cell-induced T cell immune tolerance.

Authors:  Jun Hu; Wanping Zhang; Lingjuan Xu; Lihua Hu
Journal:  Cell Death Discov       Date:  2022-06-16

2.  Phosphorylation of multiple proteins involved in ciliogenesis by Tau Tubulin kinase 2.

Authors:  Ondrej Bernatik; Petra Pejskova; David Vyslouzil; Katerina Hanakova; Zbynek Zdrahal; Lukas Cajanek
Journal:  Mol Biol Cell       Date:  2020-03-04       Impact factor: 4.138

3.  Regulation of Microtubule Nucleation in Mouse Bone Marrow-Derived Mast Cells by Protein Tyrosine Phosphatase SHP-1.

Authors:  Anastasiya Klebanovych; Vladimíra Sládková; Tetyana Sulimenko; Věra Vosecká; Martin Čapek; Eduarda Dráberová; Pavel Dráber; Vadym Sulimenko
Journal:  Cells       Date:  2019-04-11       Impact factor: 6.600

4.  Casein kinase TbCK1.2 regulates division of kinetoplast DNA, and movement of basal bodies in the African trypanosome.

Authors:  Catherine Sullenberger; Benjamin Hoffman; Justin Wiedeman; Gaurav Kumar; Kojo Mensa-Wilmot
Journal:  PLoS One       Date:  2021-04-16       Impact factor: 3.240

5.  The SH2 domain and kinase activity of JAK2 target JAK2 to centrosome and regulate cell growth and centrosome amplification.

Authors:  Aashirwad Shahi; Jacob Kahle; Chandler Hopkins; Maria Diakonova
Journal:  PLoS One       Date:  2022-01-28       Impact factor: 3.752

6.  JAK2-CHK2 signaling safeguards the integrity of the mitotic spindle assembly checkpoint and genome stability.

Authors:  Md Al Nayem Chowdhury; Shih-Wei Wang; Ching-Shu Suen; Ming-Jing Hwang; Yi-An Hsueh; Sheau-Yann Shieh
Journal:  Cell Death Dis       Date:  2022-07-18       Impact factor: 9.685

7.  Genomic diagnostics within a medically underserved population: efficacy and implications.

Authors:  Kevin A Strauss; Claudia Gonzaga-Jauregui; Karlla W Brigatti; Katie B Williams; Alejandra K King; Cristopher Van Hout; Donna L Robinson; Millie Young; Kavita Praveen; Adam D Heaps; Mindy Kuebler; Aris Baras; Jeffrey G Reid; John D Overton; Frederick E Dewey; Robert N Jinks; Ian Finnegan; Scott J Mellis; Alan R Shuldiner; Erik G Puffenberger
Journal:  Genet Med       Date:  2017-07-20       Impact factor: 8.822

8.  C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer.

Authors:  Tuck-yun Cheang; Hong-Yan Zhou; Wei Chen; Bing Zhang; Liangshuai Liu; Jianyong Yang; Shenming Wang; Heping Li
Journal:  J Transl Med       Date:  2016-02-17       Impact factor: 5.531

9.  Neuroprotective potential of imatinib in global ischemia-reperfusion-induced cerebral injury: possible role of Janus-activated kinase 2/signal transducer and activator of transcription 3 and connexin 43.

Authors:  Jieying Wang; Taomin Bai; Nana Wang; Hongyan Li; Xiangyang Guo
Journal:  Korean J Physiol Pharmacol       Date:  2020-12-20       Impact factor: 2.016

10.  AG490, a JAK2-specific inhibitor, downregulates the expression and activity of organic anion transporter-3.

Authors:  Jinghui Zhang; Chenchang Liu; Guofeng You
Journal:  J Pharmacol Sci       Date:  2018-02-08       Impact factor: 3.337

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.